SEARCH

SEARCH BY CITATION

References

  • 1
    Sax PE. Assessing risk for cardiovascular disease in patients with human immunodeficiency virus: why it matters. Circulation 2010; 121: 620622.
  • 2
    Lohse N, Hansen A, Gerstoft J, Obel N. Improved survival in HIV-infected persons: consequences and perspectives. J Antimicrob Chemother 2007; 60: 461463.
  • 3
    Brown TT, Glesby MJ. Management of the metabolic effects of HIV and HIV drugs. Nat Rev Endocrinol 2012; 8: 1121.
  • 4
    Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med 2006; 145: 397406.
  • 5
    d'Ettorre G, Francone M, Mancone M et al. Significant coronary stenosis detected by coronary computed angiography in asymptomatic HIV infected subjects. J Infect 2012; 64: 8288.
  • 6
    Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 2007; 92: 25062512.
  • 7
    Burdo TH, Lo J, Abbara S et al. Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. J Infect Dis 2011; 204: 12271236.
  • 8
    Janiszewski PM, Ross R, Despres JP et al. Hypertriglyceridemia and waist circumference predict cardiovascular risk among HIV patients: a cross-sectional study. PLoS ONE 2011; 6: e25032.
  • 9
    Morse CG, Kovacs JA. Metabolic and skeletal complications of HIV infection: the price of success. JAMA 2006; 296: 844854.
  • 10
    Mozaffarian D, Wu JH. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol 2011; 58: 20472067.
  • 11
    Calder PC. The role of marine omega-3 (n-3) fatty acids in inflammatory processes, atherosclerosis and plaque stability. Mol Nutr Food Res 2012; 56: 10731080.
  • 12
    Sun D, Krishnan A, Zaman K, Lawrence R, Bhattacharya A, Fernandes G. Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res 2003; 18: 12061216.
  • 13
    Kruger MC, Coetzer H, de Winter R, Gericke G, van Papendorp DH. Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis. Aging (Milano) 1998; 10: 385394.
  • 14
    Yamazaki RK, Brito GA, Coelho I et al. Low fish oil intake improves insulin sensitivity, lipid profile and muscle metabolism on insulin resistant MSG-obese rats. Lipids Health Dis 2011; 10: 66.
  • 15
    Parra D, Ramel A, Bandarra N, Kiely M, Martínez JA, Thorsdottir I. A diet rich in long chain omega-3 fatty acids modulates satiety in overweight and obese volunteers during weight loss. Appetite 2008; 51: 676680.
  • 16
    Harris WS, Miller M, Tighe AP, Davidson MH, Schaefer EJ. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis 2008; 197: 1224.
  • 17
    De Truchis P, Kirstetter M, Perier A et al. Reduction in triglyceride level with N-3 polyunsaturated fatty acids in HIV-infected patients taking potent antiretroviral therapy: a randomized prospective study. J Acquir Immune Defic Syndr 2007; 44: 278285.
  • 18
    Hileman CO, Carman TL, Storer NJ, Labbato DE, White CA, McComsey GA. Omega-3 fatty acids do not improve endothelial function in virologically suppressed HIV-infected men: a randomized placebo-controlled trial. AIDS Res Hum Retroviruses 2012; 28: 649655.
  • 19
    Oliveira JM, Rondo PH. Omega-3 fatty acids and hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: systematic review and meta-analysis. HIV Clin Trials 2011; 12: 268274.
  • 20
    Wohl DA, Tien HC, Busby M et al. Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy-associated hypertriglyceridemia. Clin Infect Dis 2005; 41: 14981504.
  • 21
    Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412419.
  • 22
    Harris WS. The omega-3 index: clinical utility for therapeutic intervention. Curr Cardiol Rep 2010; 12: 503508.
  • 23
    Miller M, Stone NJ, Ballantyne C et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2011; 123: 22922333.
  • 24
    ORIGIN Trial Investigators, Bosch J, Gerstein HC, Dagenais GR et al. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med 2012; 367: 309318.
  • 25
    Boccara F, Lang S, Meuleman C et al. HIV and coronary heart disease: time for a better understanding. J Am Coll Cardiol 2013; 61: 511523.
  • 26
    Aarsetoey H, Aarsetoey R, Lindner T, Staines H, Harris WS, Nilsen DW. Low levels of the omega-3 index are associated with sudden cardiac arrest and remain stable in survivors in the subacute phase. Lipids 2011; 46: 151161.
  • 27
    Park Y, Lim J, Lee J, Kim SG. Erythrocyte fatty acid profiles can predict acute non-fatal myocardial infarction. Br J Nutr 2009; 102: 13551361.
  • 28
    Kuller LH, Tracy R, Belloso W et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008; 5: e203.
  • 29
    McComsey GA, Kitch D, Sax PE et al. Associations of inflammatory markers with AIDS and non-AIDS clinical events after initiation of antiretroviral therapy (ART): AIDS Clinical Trials Group A5224s, a substudy of ACTG A5202. XIX International AIDS Conference. Washington, DC, July 2012 [Abstract THLBB06].
  • 30
    Rangel-Huerta OD, Aguilera CM, Mesa MD, Gil A. Omega-3 long-chain polyunsaturated fatty acids supplementation on inflammatory biomakers: a systematic review of randomised clinical trials. Br J Nutr 2012; 107 (Suppl 2): S159S170.
  • 31
    Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006; 83 (6 Suppl): 1505S1519S.
  • 32
    Calder PC. n-3 polyunsaturated fatty acids as pharmacologic agents: a fishy tale? Nutrition 1997; 13: 10021004.
  • 33
    Sethi S. Inhibition of leukocyte-endothelial interactions by oxidized omega-3 fatty acids: a novel mechanism for the anti-inflammatory effects of omega-3 fatty acids in fish oil. Redox Rep 2002; 7: 369378.
  • 34
    Novak TE, Babcock TA, Jho DH, Helton WS, Espat NJ. NF-kappa B inhibition by omega -3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription. Am J Physiol Lung Cell Mol Physiol 2003; 284: L84L89.
  • 35
    Lee YH, Bae SC, Song GG. Omega-3 polyunsaturated fatty acids and rheumatoid arthritis treatment: a meta-analysis. Arch Med Res 2012; 43: 356362.
  • 36
    Thusgaard M, Christensen JH, Mørn B et al. Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: a randomized, double-blind, placebo-controlled study. Scand J Infect Dis 2009; 41: 760766.
  • 37
    Ross L, Zhao H, Pappa K. A pilot study of the impart of switch of fosamprenavir and addition of LOVAZA for treatment of hypertriglyceridemia in HIV-infected sujects on antiretroviral therapy. Program of the 13th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV. 2011, Rome.
  • 38
    Orchard TS, Pan X, Cheek F, Ing SW, Jackson RD. A systematic review of omega-3 fatty acids and osteoporosis. Br J Nutr 2012; 107 (Suppl 2): S253S260.
  • 39
    van Vonderen M, Mallon P, Murray B et al. for MEDICLAS Study Group. Changes in Bone Biomarkers in ARV-naïve HIV+ Men Randomized to NVP/LPV/r or AZT/3TC/LPV/r Help Explain Limited Loss of Bone Mineral Density over the First 12 Months after ART Initiation. 18th Conference on Retroviruses and Opportunistic Infections. Boston, MA, February 2011 [Abstract #833].
  • 40
    Saag K, Lindsay R, Kriegman A, Beamer E, Zhou W. A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density. Bone 2007; 40: 12381243.
  • 41
    von Schacky C. A review of omega-3 ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levels. Vasc Health Risk Manag 2006; 2: 251262.
  • 42
    Tsitouras PD, Gucciardo F, Salbe AD, Heward C, Harman SM. High omega-3 fat intake improves insulin sensitivity and reduces CRP and IL6, but does not affect other endocrine axes in healthy older adults. Horm Metab Res 2008; 40: 199205.
  • 43
    Ahrén B, Mari A, Fyfe CL. Effects of conjugated linoleic acid plus n-3 polyunsaturated fatty acids on insulin secretion and estimated insulin sensitivity in men. Eur J Clin Nutr 2009; 63: 778786.